Analysts expect Beta Bionics, Inc. to report revenue of 33.67 M for Q3 26, against a range of 30.73 M to 36.60 M. The most recent reported quarter, Q2 26, came in at 32.01 M, a 6.1% beat against the 30.17 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 16.70 M | 20.44 M | 17.64 M | 23.24 M | 27.25 M | 32.12 M | 27.63 M | 32.01 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | - | 22.71 M | 17.92 M | 21.68 M | 25.81 M | 31.58 M | 29.90 M | 32.55 M | 36.60 M | 31.38 M | 36.63 M | 46.41 M | 55.10 M | 49.71 M | 60.98 M | 72.55 M | ||||||||||
| Low Estimate | - | 19.66 M | 15.14 M | 19.27 M | 23.21 M | 26.41 M | 25.22 M | 27.79 M | 30.73 M | 29.10 M | 32.38 M | 40.03 M | 45.10 M | 45.12 M | 50.04 M | 63.67 M | ||||||||||
| Consensus Estimate | - | 21.19 M | 16.53 M | 20.48 M | 24.51 M | 28.99 M | 27.56 M | 30.17 M | 33.67 M | 30.24 M | 34.50 M | 43.22 M | 50.10 M | 47.42 M | 55.51 M | 68.11 M |
Analysts expect Beta Bionics, Inc. to report earnings per share of -0.54 for Q3 26, against a range of -0.56 to -0.52. The most recent reported quarter, Q2 26, came in at -0.53, a 5.4% beat against the -0.56 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.57 | -2.72 | -0.93 | -0.39 | -0.33 | -0.30 | -0.49 | -0.53 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | - | -0.83 | -0.47 | -0.44 | -0.40 | -0.36 | -0.48 | -0.54 | -0.52 | -0.49 | -0.45 | -0.53 | -0.49 | -0.52 | -0.27 | -0.35 | ||||||||||
| Low Estimate | - | -0.93 | -0.51 | -0.54 | -0.46 | -0.42 | -0.54 | -0.58 | -0.56 | -0.57 | -0.51 | -0.59 | -0.59 | -0.56 | -0.33 | -0.41 | ||||||||||
| Consensus Estimate | - | -0.88 | -0.49 | -0.49 | -0.43 | -0.39 | -0.51 | -0.56 | -0.54 | -0.53 | -0.48 | -0.56 | -0.54 | -0.54 | -0.30 | -0.38 |
Pull Wall Street consensus for Beta Bionics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=BBNX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "BBNX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=BBNX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();